Fundraising Fox
🦊/People
Sign in

Raj Bakhru, CFA, CISSP

Founder

Managing Member at Blueflame AI

New York, New York, United States

FoundedBlueflame AI

Find your path to Raj

674 people in our graph share verified history with Raj — schools, employers, funds. One of them is your warm intro.

Chris BischoffunlockedRaj: together at Goldman Sachs (2005–2008)
×9Raj: together at Goldman Sachs
Raj: together at ACA Group
Raj: together at Highbridge Capital Management

About

Raj Bakhru is the Founder, Chairman, Chief Executive Officer, and Chief Business Officer of Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company he led from formation through its Nasdaq IPO and the acquisition of its lead compound, CAD-1005. The company's pipeline includes CAD-1005, an IV 12-LOX inhibitor for Heparin-Induced Thrombocytopenia and Cardiac Surgery Associated-Acute Kidney Injury, and Tecarfarin, an oral vitamin K antagonist. Bakhru holds the CFA and CISSP designations, is a former U.S. Marine aviator, and has been recognized as an EY Entrepreneur of the Year and BioFlorida Executive of the Year.

Managing Member at Blueflame AI

Co-founders at Blueflame AI

RBRaj Bakhru, CFA, CISSP
Raj Bakhru, CFA, CISSPFounder

Founder at Blueflame AI

Co-founders at Blueflame AI

RBRaj Bakhru
Raj BakhruManaging Member

Experience

  1. DatasiteGeneral Manager, Blueflame AI / Data & Intelligencecurrent2025 — presentNew York, New York, United States
  2. BlueFlame AIChief Executive Officer2023 — 2025New York, NY
  3. ACA GroupSenior Adviser2023 — 2024
  4. ACA GroupChief Strategy Officer2022 — 2023New York, United States
  5. ACA GroupChief Innovation Officer - Head of RegTech, ESG, Strategy, and M&A2019 — 2022
  6. ACA GroupPartner, Division Head - Cybersecurity and Risk at ACA Aponix2015 — 2019NY, NY
  7. Aponix Financial TechnologistsFounder & CEO2014 — 2015White Plains, NY
  8. Kepos Capital, L.P.Technology2010 — 2014NY, NY
  9. Highbridge Capital ManagementVice President2008 — 2010
  10. Goldman Sachs Asset ManagementApplication Developer2005 — 2008

Skills & more

Trading Systems28Bloomberg5Sybase1Derivatives15Electronic Trading11Quantitative Finance15Hedge Funds24Fixed Income10Market Data4Options11Equities16Credit Derivatives2
+10 moreAsset ManagementEquity DerivativesFX OptionsCybersecurityCloud SecurityPrivate EquityDue DiligenceFinancial ServicesIT RiskPrivacy
  • Amazon Web Services Solutions Architect Associate — Amazon Web Services (AWS)
  • CISSP — ISC(2)
  • Chartered Financial Analyst (CFA) — CFA Institute

From Raj's professional profile.

Frequently asked questions

Who is Raj Bakhru, CFA, CISSP?
Raj Bakhru is the Founder, Chairman, Chief Executive Officer, and Chief Business Officer of Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company he led from formation through its Nasdaq IPO and the acquisition of its lead compound, CAD-1005. The company's pipeline includes CAD-1005, an IV 12-LOX inhibitor for Heparin-Induced Thrombocytopenia and Cardiac Surgery Associated-Acute Kidney Injury, and Tecarfarin, an oral vitamin K antagonist. Bakhru holds the CFA and CISSP designations, is a former U.S. Marine aviator, and has been recognized as an EY Entrepreneur of the Year and BioFlorida Executive of the Year.
Where does Raj Bakhru, CFA, CISSP work?
Raj Bakhru, CFA, CISSP is Founder of Blueflame AI.
What companies did Raj Bakhru, CFA, CISSP found?
Raj Bakhru, CFA, CISSP founded Blueflame AI.
Where did Raj Bakhru, CFA, CISSP go to school?
Raj Bakhru, CFA, CISSP studied at Columbia University (BS, Computer Engineering).

Founder mafias

Same school

Shared employers